Humana takes aim at Mallinckrodt's 'ill-gotten' Acthar gains in lawsuit

Health insurer Humana has had enough of Mallinckrodt, and the drugmaker’s expensive, controversial treatment Acthar gel, which was first approved for a broad range of conditions by the FDA back in 1952.